EcoDrugPlus

Epoxide Hydrolase 2

Ensembl ID : ENSBBBG00000011228
Gene Symbol: EPHX2
3 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSBBBG00000023345
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSBBBG00000014015
Gene Symbol: ERBB3
3 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSBBBG00000010300
Gene Symbol: ERBB4
3 Cross references
320 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSBBBG00000022747
Gene Symbol: ESR2
3 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSBBBG00000018454
Gene Symbol: ESRRG
3 Cross references
206 Possible Orthologues:

Exportin 1

Ensembl ID : ENSBBBG00000016353
Gene Symbol: XPO1
3 Cross references
296 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSBBBG00000014941
Gene Symbol: FDPS
3 Cross references
268 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSBBBG00000006569
Gene Symbol: FDFT1
3 Cross references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSBBBG00000012087
Gene Symbol: FNTA
2 Cross references
216 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSBBBG00000000470
Gene Symbol: FNTB
3 Cross references
211 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSBBBG00000015607
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).